An outpatient clinic successfully integrated a pharmacist into a multidisciplinary PACT focused on veterans with poorly controlled type 2 diabetes. The clinic's initial experience suggests that frequent pharmacist interventions have a positive impact in promoting appropriate insulin use in this high-risk patient population.

Adoption of continuous glucose monitoring (CGM) technology in clinical practice has increased over the past few years with numerous studies demonstrating its benefit in persons with diabetes. In addition, the use of CGM systems is now recommended in multiple guidelines for diabetes care. Implementation of personal‐ and professional‐use CGM technology can facilitate patient‐centered discussions in clinical decision making and empower behavioral change. Pharmacists can incorporate CGM into diabetes management practices to help optimize therapy and overcome therapeutic inertia. This “how to” guide is written for pharmacists who are interested in integrating CGM into their clinical practice to improve care for those living with diabetes. It provides an overview of the different CGM systems available and describes the differences between personal‐ and professional‐use CGM to facilitate decision making for use in clinical practice. It also discusses considerations for use, candidates for coverage, billing for CGM services, data interpretation, and documentation. Lessons learned and advice for implementing into clinical practice are also provided.

No abstract

No abstract